Hyster-Yale, Inc. HY
30.97
0.15
0.49%
as of 25 Sep
- Market cap
- $552.6M
- P/E
- 0.0×
Follow HY
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
230.38 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.17 | 0.14 | 0.16 | 0.18 | |
P/FCF ratio |
11.75 | 20.19 | 19.00 | 37.38 | |
P/Operating CF |
17.60 | 9.29 | (17.61) | 37.60 | |
P/B ratio |
1.21 | 1.10 | 1.33 | 1.59 | |
Price to Tangible BV |
1.45 | 1.35 | 1.66 | 2.04 | |
EV/Sales |
0.25 | 0.21 | 0.24 | 0.27 | |
EV/EBITDA |
10.30 | 31.33 | 0.00 | 0.00 | |
EV/Operating CF |
8.84 | 9.13 | 9.99 | 12.36 | |
EV/FCF |
17.54 | 30.25 | 29.34 | 56.95 | |
Quick Ratio |
0.57 | 0.61 | 0.56 | 0.56 | |
Current Ratio |
1.39 | 1.34 | 1.31 | 1.28 | |
Net Debt/EBITDA |
23.19 | (10.38) | (19.24) | (45.67) | |
Debt/Assets |
19.09% | 19.04% | 20.29% | 20.82% | |
Debt/Equity |
0.73 | 0.81 | 0.91 | 1.02 | |
Asset Turnover |
1.85 | 1.86 | 1.82 | 1.75 | |
Operating CF/Net income |
(16.13) | (1.08) | 1.08 | (0.53) | |
Capex/Depreciation |
(1.22) | (1.91) | (0.80) | (1.27) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
15.59% | 15.89% | 19.01% | 17.75% | |
Intangible Assets out of Total Assets |
0.04 | 0.04 | 0.04 | 0.04 | |
Share Based Compensation of Revenue |
0.21% | (0.09%) | 0.55% | 0.17% | |
Graham Net Nets |
(0.12) | (0.38) | (0.38) | (0.41) | |
Graham Number |
10.48 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
0.43% | (11.41%) | (17.19%) | (18.71%) | |
Free Cash Flow Yield |
8.51% | 4.95% | 5.26% | 2.68% | |
Revenue per Share |
55.26 | 52.25 | 44.62 | 45.38 | |
Operating CF per Share |
2.09 | 3.20 | (1.85) | 0.93 | |
Capex per Share |
(0.80) | (1.30) | (0.52) | (0.79) | |
Free Cash Flow per Share |
1.29 | 1.90 | (2.37) | 0.14 | |
Cash per Share |
4.01 | 6.97 | 4.59 | 4.05 | |
Shareholders Equity per Share |
30.50 | 26.96 | 24.38 | 21.99 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
30.50 | 26.96 | 24.38 | 21.99 | |
Free Cash Flow |
22.90 | 33.60 | (42.20) | 2.50 | |
Working Capital |
406.80 | 345.20 | 312.20 | 277.20 | |
Capital Expenditures |
(14.20) | (22.90) | (9.30) | (14.20) | |
Net Current Asset Value |
(76.40) | (197.30) | (218.60) | (257.50) | |
EV/EBIT |
20.58 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.02 | 0.01 | 0.02 | |
Net Profit Margin |
(0.23%) | (5.69%) | (3.84%) | (3.89%) | |
Price to Operating Income |
13.78 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
531.55 | 489.00 | 488.65 | 498.45 | |
Average Payables |
504.95 | 428.35 | 441.50 | 448.90 | |
Average Inventory |
797.80 | 694.30 | 708.25 | 702.05 | |
Average Assets |
2,116.45 | 2,024.90 | 2,006.70 | 2,001.65 | |
Average Common Equity |
537.15 | 477.75 | 474.35 | 471.40 |
Columns are period end dates